Ina Koch

4.6k total citations
33 papers, 1.6k citations indexed

About

Ina Koch is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Ina Koch has authored 33 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 9 papers in Pulmonary and Respiratory Medicine and 8 papers in Molecular Biology. Recurrent topics in Ina Koch's work include Pharmacogenetics and Drug Metabolism (5 papers), Lung Cancer Treatments and Mutations (4 papers) and Drug Transport and Resistance Mechanisms (4 papers). Ina Koch is often cited by papers focused on Pharmacogenetics and Drug Metabolism (5 papers), Lung Cancer Treatments and Mutations (4 papers) and Drug Transport and Resistance Mechanisms (4 papers). Ina Koch collaborates with scholars based in Germany, United States and Switzerland. Ina Koch's co-authors include Leszek Wojnowski, Oliver Burk, Elisabeth Hustert, Ulrich M. Zanger, Michel Eichelbaum, Jürgen Brockmöller, Michael Lindner, Falko Fend, Renzo Wolbold and P. Neuhaus and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and Blood.

In The Last Decade

Ina Koch

31 papers receiving 1.6k citations

Peers

Countries citing papers authored by Ina Koch

Since Specialization

Citations

This map shows the geographic impact of Ina Koch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ina Koch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ina Koch more than expected).

Fields of papers citing papers by Ina Koch

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ina Koch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ina Koch. The network helps show where Ina Koch may publish in the future.

Co-authorship network of co-authors of Ina Koch

This figure shows the co-authorship network connecting the top 25 collaborators of Ina Koch. A scholar is included among the top collaborators of Ina Koch based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ina Koch. Ina Koch is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Assessing lung cancer progression and survival with infrared spectroscopy of blood serum 2025 ·BMC Medicine ·Kosmas V. Kepesidis, (unknown), (unknown), (unknown), Frank Fleischmann, (unknown), (unknown), Ina Koch, Niels Reinmuth, Amanda Tufman, Jürgen Behr, Mihaela Žigman	0
2	Comparison of the sensitivity of different criteria to select lung cancer patients for screening in a cohort of German patients 2023 ·Cancer Medicine ·Julia Walter, Diego Kauffmann‐Guerrero, Thomas Muley, Martin Reck, Jan Fuge, Andreas Günther, Raphael W. Majeed, Rajkumar Savai, Ina Koch, Julien Dinkel, Christian Schneider, (unknown), (unknown), Farkhad Manapov, Michael Thomas, Kathrin Kahnert, H. Winter, Jürgen Behr, Martin C. Tammemägi, Amanda Tufman	2
3	Infrared molecular fingerprinting of blood-based liquid biopsies for the detection of cancer 2021 ·eLife ·Marinus Huber, Kosmas V. Kepesidis, (unknown), Frank Fleischmann, Ernst E. Fill, (unknown), Ina Koch, Katrin Milger, Thomas Kolben, Gerald Bastian Schulz, Friedrich Jokisch, Jürgen Behr, Nadia Harbeck, Maximilian F. Reiser, Christian G. Stief, Ferenc Krausz, Mihaela Žigman	26
4	A pre-clinical validation plan to evaluate analytical sensitivities of molecular diagnostics such as BD MAX MDR-TB, Xpert MTB/Rif Ultra and FluoroType MTB 2020 ·PLoS ONE ·Markus Beutler, Sara Plesnik, (unknown), (unknown), Norbert Heinrich, Samuel G. Schumacher, Michael Lindner, Ina Koch, (unknown), (unknown), Sabine Hofmann-Thiel, Harald Hoffmann	13
5	Quality assessment of tissue samples stored in a specialized human lung biobank 2019 ·PLoS ONE ·Michael Lindner, Alicia Morresi‐Hauf, (unknown), Alexander Hapfelmeier, Rudolf Hatz, Ina Koch	6
6	Pleurectomy/decortication and hyperthermic intrathoracic chemoperfusion using cisplatin and doxorubicin for malignant pleural mesothelioma 2019 ·Journal of Thoracic Disease ·Laura V. Klotz, Michael Lindner, Martin Eichhorn, U Grützner, Ina Koch, H. Winter, Teresa Kauke, Thomas Duell, Rudolf Hatz	20
7	Preclinical validation and imaging of Wnt-induced repair in human 3D lung tissue cultures 2015 ·European Respiratory Journal ·Franziska E. Uhl, Sarah Vierkotten, Darcy E. Wagner, Gerald Burgstaller, Rita Costa, Ina Koch, Michael Lindner, Silke Meiners, Oliver Eickelberg, Mélanie Königshoff	113
8	Blood-sampling collection prior to surgery may have a significant influence upon biomarker concentrations measured 2015 ·Clinical Proteomics ·Nicolas Kahn, J. Riedlinger, Markus Roeßler, Christina Rabe, Michael Lindner, Ina Koch, (unknown), Felix Herth, (unknown), Michael Meister, Thomas R Muley	9
9	Interleukin-22 Is Frequently Expressed in Small- and Large-Cell Lung Cancer and Promotes Growth in Chemotherapy-Resistant Cancer Cells 2013 ·Journal of Thoracic Oncology ·Sebastian Kobold, (unknown), Till S. Clauditz, (unknown), Sarah Minner, Amanda Tufman, (unknown), Michael Lindner, Ina Koch, Simon Heidegger, (unknown), Max Schnurr, Rudolf M. Huber, Waldemar Wilczak, Stefan Endres	53
10	Gli1 Mediates Lung Cancer Cell Proliferation and Sonic Hedgehog-Dependent Mesenchymal Cell Activation 2013 ·PLoS ONE ·Olga María Bermúdez, Elisabeth Hennen, Ina Koch, Michael Lindner, Oliver Eickelberg	76
11	The impact of cyclin D1 mRNA isoforms, morphology and p53 in mantle cell lymphoma: p53 alterations and blastoid morphology are strong predictors of a high proliferation index 2012 ·Haematologica ·Julia Slotta‐Huspenina, Ina Koch, Laurence de Leval, Gisela Keller, Margit Klier, Karin Bink, Markus Kremer, Mark Raffeld, Falko Fend, Leticia Quintanilla-Martı́nez	49
12	ADAM17 Regulates Epidermal Growth Factor Receptor Expression through the Activation of Notch1 in Non–Small Cell Lung Cancer 2010 ·Cancer Research ·(unknown), Stefan Seidl, (unknown), Lars Michel, (unknown), (unknown), Katja Specht, Ina Koch, Tibor Schuster, Rebekka Grundler, Marcus Kremer, Falko Fend, Jens T. Siveke, Christian Peschel, Justus Duyster, Tobias Dechow	85
13	Differential diagnosis of cyclin D2+ mantle cell lymphoma based on fluorescence in situ hybridization and quantitative real-time-PCR 2009 ·Haematologica ·Leticia Quintanilla-Martı́nez, Julia Slotta‐Huspenina, Ina Koch, Margit Klier, Eric D. Hsi, Laurence de Leval, Wolfram Klapper, Stefan Gesk, Reiner Siebert, (unknown)	28
14	Efficient shRNA delivery into B and T lymphoma cells using lentiviral vector-mediated transfer 2008 ·Journal of Hematopathology ·Nataša Anastasov, Margit Klier, Ina Koch, (unknown), Heinz Höfler, Falko Fend, Leticia Quintanilla‐Martinez	33
15	Cyclin D1 positive multiple myeloma: Predominance of the short, 3′UTR-deficient transcript is associated with high cyclin D1 mRNA levels in cases with t(11;14) translocation, but does not correlate with proliferation rate or genomic deletions 2007 ·Leukemia Research ·Julia Slotta‐Huspenina, Ina Koch, Manfred Richter, Karin Bink, Marcus Kremer, Katja Specht, Jens Krugmann, Leticia Quintanilla-Martı́nez, Falko Fend	10
16	Real-time Quantitative RT-PCR Shows Variable, Assay-dependent Sensitivity to Formalin Fixation: Implications for Direct Comparison of Transcript Levels in Paraffin-embedded Tissues 2006 ·Diagnostic Molecular Pathology ·Ina Koch, Julia Slotta‐Huspenina, (unknown), Nataša Anastasov, Heinz Höfler, Leticia Quintanilla-Martı́nez, Falko Fend	38
17	Limited contribution of CYP3A5 to the hepatic 6?-hydroxylation of testosterone 2004 ·Naunyn-Schmiedeberg s Archives of Pharmacology ·Landry K. Kamdem, Ingolf Meineke, Ina Koch, Ulrich M. Zanger, (unknown), Leszek Wojnowski	16
18	Molecular Mechanisms of Polymorphic CYP3A7 Expression in Adult Human Liver and Intestine 2002 ·Journal of Biological Chemistry ·Oliver Burk, Heike Tegude, Ina Koch, Elisabeth Hustert, Renzo Wolbold, Hartmut Glaeser, Kathrin Klein, Martin F. Fromm, Andreas K. Nuessler, P. Neuhaus, Ulrich M. Zanger, Michel Eichelbaum, Leszek Wojnowski	156
19	Interleukin 1 modulates growth of human renal carcinoma cells in vitro 1995 ·British Journal of Cancer ·Ina Koch, H. Depenbrock, S. Danhauser-Riedl, (unknown), (unknown)	15
20	Expression of a hepatitis B virus transcript containing fused mitochondrial-tike domains in human hepatoma cells 1989 ·Virology ·Ina Koch, P. H. Hofschneider, Rajen Koshy	4

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact